Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

Navega Therapeutics Gets CIRM Grant for Chronic Pain Treatment

PR Newswire
by PR Newswire0240
 Next-generation AAV gene therapy targets intractable chronic pain Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant...
Clinical Research, Pharma & Healthcare Financing

Newronika Gets FDA IDE for U.S. Trial of Adaptive DBS System

PR Newswire
by PR Newswire0254
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the U.S....
Clinical Research, Pharma & Healthcare Financing

NABR Applauds CITES Decision on Cambodia’s Long-Tailed Macaques

PR Newswire
by PR Newswire0202
The National Association for Biomedical Research (NABR) commends the CITES Standing Committee’s decision not to enact a trade suspension on long-tailed macaques (Macaca fascicularis) from Cambodia....
Clinical Research, Pharma & Healthcare Financing

Zentalis Pharmaceuticals Announces Inducement Grant under Nasdaq

GlobeNewswire
by GlobeNewswire0241
Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced...
Clinical Research, Pharma & Healthcare FinancingDigital Health, Technology & InnovationWorkforce Development & Leadership

Viventium Enhances Scheduling with Open Shift Management

GlobeNewswire
by GlobeNewswire0285
Viventium, the leading SaaS-based human capital management platform serving the healthcare industry, announces the addition of Open Shift Management to Viventium Scheduling, Viventium’s proprietary and innovative...
Clinical Research, Pharma & Healthcare Financing

Immunome Closes Upsized Offering, Underwriters Exercise Option

Business Wire
by Business Wire0193
Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public...
Clinical Research, Pharma & Healthcare Financing

Inhalon Biopharma’s Inhaled RSV Antibody to Enter Trials

Business Wire
by Business Wire0244
New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations nhalon Biopharma, Inc. (Inhalon),...